Up to $70 million to be awarded to advance Alzheimer's Disease clinical trials

(Brigham and Women's Hospital) The National Institutes of Health (NIH) is expected to award up to $70 million over five years to three physician-scientists to launch the Alzheimer's Clinical Trials Consortium (ACTC). Reisa Sperling, MD, director of the Center for Alzheimer Research and Treatment at Brigham and Women's Hospital, will collaborate with colleagues to accelerate clinical trials for Alzheimer's disease and related dementias.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news